Effects of the new beta-adrenoceptor blocking agent, S-596 on the peripheral autonomic nervous system and smooth muscles.
The effects of the new beta-adrenoceptor blocking agent, S-596, on the peripheral autonomic nervous system and smooth muscles were studied in comparison with propranolol. In urethane or alpha-chloralose anesthetized cats S-596 (10 micrograms/kg, i.v.) antagonized the cardiovascular responses induced by isoproterenol. S-596, in doses ranging from 100 to 300 micrograms/kg (i.v.) reduced the contractions of the nictitating membrane induced by electrical stimulation of preganglionic and postganglionic fibers to the superior cervical ganglion. Higher doses of S-596 were required to depress the effects of noradrenaline and tyramine. In spinal cats the tyramine and noradrenaline dose-response curve was shifted to the right by S-596. In isolated rat aortic strips S-596 displaced the noradrenaline dose-response curve to the right in a parallel fashion indicating a competitive antagonism. Its potency was about one tenth of that of phentolamine. These results suggest that S-596 possesses both alpha-and beta-adrenoceptor blocking activities.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000758:Anesthesia; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects*; D002415:Cats; D002818:Cordotomy; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007422:Intestines / Q000187:drug effects; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D011412:Propanolamines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012867:Skin / Q000294:innervation; D014132:Trachea / Q000378:metabolism; D014599:Uterus / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C024523:arotinolol